Lemonaid Health
Listing details
About
Lemonaid Health is a telehealth platform offering GLP-1 weight loss treatment through a three-step process: online health assessment, U.S.-based medical team review, and home delivery of prescribed medications. The service offers both compounded and brand-name GLP-1 injectables, with pricing starting at $129/month for eligible patients. Lemonaid is headquartered in San Francisco at 870 Market Street.
Is this your clinic? to update your details.
This Clinic May Be a Good Fit If You
- Prefer telehealth consultations from home
- Are looking for Semaglutide, Tirzepatide
Pricing
This clinic has not published monthly program pricing. Ask directly, or compare clinics that have.
Insurance Accepted
This clinic has not listed accepted insurance plans. Call to verify coverage before booking, or review how major insurers cover GLP-1 medications.
Clinic Details
Own this clinic? Patients searching for GLP-1 treatment in San Francisco are landing on this page. Claim your free listing so their inquiries reach you.
Learn More About GLP-1 Weight Loss
About this listing: Data for Lemonaid Health was compiled from Google Business Profile and the clinic’s public website. It has not been verified by the clinic owner. Pricing, medications, and hours can change. Always confirm details directly with the clinic before booking.
Is this your clinic? to manage your information, respond to inquiries, and display your current pricing and medications.
Patient Reviews
No patient reviews yet. Be the first to share your experience!
Frequently Asked Questions: Lemonaid Health
Lemonaid Health offers telehealth (virtual) appointments. You can consult with a provider from home without visiting the San Francisco location in person.
Lemonaid Health has confirmed availability of: Semaglutide, Tirzepatide. Availability and eligibility can change. Contact the clinic to verify current offerings.
Lemonaid Health is located at , San Francisco, California. Phone: (888) 536-2267. Visit their website for directions and parking.